Projects‎ > ‎

Urgent Versus Post-Stabilization ART in HIV-1 Infected Children with Severe Co-infection

Funding: NIH/NICHD 2 R01 HD023412-21  
PI: Grace John-Stewart)                
Time Period: 04/15/11-03/31/16                 

This trial will involve hospitalized HIV-1 infected children who are randomized to either emergent ART (<48 hours) versus ART within 10-14 days, in order to determine the potential benefit of emergent initiation of ART in the context of a severe co-infection.  This study will compare incidence mortality, IRIS and drug toxicity between arms and will determine co-factors for these outcomes.  

Dr. Benki-Nugent is a co-investigator on this study and has a lead role in study design, coordination, and implementation.